In Defense of Imperfect Progress: Why Anthropic's Delay Matters More Than the Critics Think

Maha’s critique is a serious one, and it deserves a serious answer. She is right to warn against treating basic corporate responsibility as a triumph. She is right that we should not confuse prudence with heroism, or allow AI firms to collect moral credit for meeting standards that ought to be non-negotiable. But where I part company with her is on the central question: should Anthropic’s decision to delay a model release be publicly recognized as meaningful? My answer remains yes.

Not because Anthropic is above criticism. Not because voluntary restraint is enough. And certainly not because self-regulation should substitute for law. But because in the AI industry we actually have, rather than the one we wish we had, a company choosing to slow down under intense competitive pressure is not trivial. It is one of the few concrete signs of restraint available to us.

In a market built to reward speed, a voluntary pause is not the end of the safety conversation. But it is part of it.

Voluntary restraint matters precisely because the industry is underregulated

Maha’s position makes more sense in a world where robust guardrails already exist. In that world, delaying a release for safety reasons would indeed look like little more than compliance with baseline expectations. But frontier AI is not operating in that world. It is being developed in a largely unregulated environment, with immense commercial pressure to ship, iterate, and capture mindshare fast.

That context matters. Every major lab is competing not only for users, but for investor confidence, developer ecosystems, enterprise contracts, and the narrative of momentum. In such an environment, delay carries real costs. It can mean lost headlines, slower monetization, and a perception—fair or not—of falling behind. So when a company absorbs those costs and chooses caution, that is not morally sufficient, but it is operationally significant.

We do not need to romanticize the decision to recognize the incentive structure around it. In fact, doing so is exactly what serious analysis requires.

Pharma and aviation are the wrong comparison

Maha also invoked industries like pharmaceuticals and aviation to argue that we should not celebrate companies for acting responsibly. The comparison sounds intuitive, but it misses a crucial distinction: those sectors are governed by decades of regulation, formal review, certification regimes, legal liability, and deeply institutionalized safety cultures. AI, by contrast, has almost none of that.

Pharmaceuticals face mandatory trials, pre-market approvals, post-market surveillance, and regulators with real power.
Aviation operates within dense systems of certification, maintenance requirements, incident reporting, and independent investigation.
Frontier AI is still largely governed by internal policies, voluntary commitments, selective disclosure, and fragmented public oversight.

That is not a defense of the status quo. It is an argument for seeing it clearly. In pharma or aviation, “doing the responsible thing” is often enforced by law and procedure. In AI, it is frequently discretionary. That is precisely why discretionary restraint matters more than critics sometimes allow.

To say “we should not applaud companies for doing the minimum” is a sound principle in a mature regulatory system. In an immature one, it can become a kind of moral purism that ignores how governance actually emerges. Before rules harden, norms matter. Before oversight becomes external, much of it is internal. And before compliance can be mandatory, it often has to be culturally rewarded.

Pragmatism is not complacency

The strongest version of Maha’s argument is not that safety is unimportant, but that publicly rewarding a delay risks lowering the bar. If every act of caution is treated as visionary leadership, firms can convert ordinary responsibility into reputational gain while avoiding binding obligations. That concern is legitimate. But it still does not follow that the delay should be dismissed as meaningless. The better response is to name the act for what it is: a limited, consequential decision that deserves recognition without absolution.

That distinction matters. Recognition is not exoneration. To say Anthropic’s delay matters is not to say Anthropic should be trusted by default, or that its internal processes are enough, or that lawmakers can stand down. It is simply to say that in a sector still governed more by incentives and norms than by enforceable public rules, a company choosing not to ship immediately is making a decision worth analyzing seriously.

Pragmatism, in this context, means refusing a false choice between criticism and acknowledgment. We can insist on regulation, independent oversight, transparency, and accountability while also recognizing that present-day behavior is shaped by present-day signals. If we care about safety in the near term, then we have to care about what companies are taught to believe the market, the press, and the policy community will reward.

If every pause is treated as weakness, we will get fewer pauses

This is the part critics often understate. Public reaction does not just interpret corporate behavior; it helps structure it. Executives and boards watch what happens when a lab slows down. Competitors watch. Investors watch. Employees watch. If the lesson they take away is that delay brings only ridicule, suspicion, and lost ground—while acceleration brings attention, adoption, and prestige—then we should not be surprised when caution steadily disappears from the decision calculus.

That does not mean companies are entitled to praise. It means incentives are real. In a race dynamic, even modest forms of reputational reinforcement can matter. A public environment that can distinguish between “moved fast” and “stopped to assess risk” is better than one that collapses both into the same story of inevitable corporate cynicism. Not because cynicism is always wrong, but because it can become politically self-defeating when it erases meaningful differences in conduct.

One of the few tools civil society currently has is normative signaling. Before formal law arrives, expectations are built socially: through media coverage, expert commentary, employee pressure, procurement standards, and user trust. If delaying a release for safety reasons becomes legible as a serious, defensible choice rather than an embarrassing concession, other firms may feel more permission—or more pressure—to do the same. That is not the whole solution. But it is not nothing.

The right response is conditional approval tied to stronger demands

So what should recognition look like if it is not meant to become free public relations? It should be specific, limited, and paired with clear expectations. A responsible public response to Anthropic’s delay might include all of the following:

Acknowledging the significance of the pause without treating it as evidence of exceptional virtue.
Asking for more transparency about what concerns triggered the delay, what testing was done, and what thresholds must be met before release.
Pressing for independent scrutiny rather than relying solely on internal evaluation and self-description.
Expecting consistency so that “safety” is not invoked selectively when convenient and abandoned when market pressure intensifies.
Demanding support for public regulation so that future restraint is not merely voluntary.

That is a much stronger standard than either uncritical praise or dismissive refusal. It turns acknowledgment into leverage. It says, in effect: this delay was the right move, and now show us the process, the evidence, and the governance structures that make the decision credible.

There is also a broader political reason to resist all-or-nothing judgments. Emerging technologies are rarely governed in one clean institutional leap. They are governed through a messy accumulation of norms, disclosures, precedents, scandals, internal checks, external pressure, and eventually law. During that messy period, imperfect acts of restraint can help establish expectations that later become formalized. Refusing to see any value in those acts does not create stronger governance; sometimes it simply obscures the path by which stronger governance becomes thinkable.

None of this makes Anthropic uniquely admirable. If it later uses safety rhetoric opportunistically, withholds crucial information, or resumes racing when convenient, criticism will be warranted. And if governments allow a handful of firms to define “responsible AI” on their own terms indefinitely, that will be a failure of public policy, not a success of private ethics. But those truths do not erase the narrower point at issue here: when a major AI lab delays a release under competitive pressure, that decision matters.

What matters about it is not that it proves the company is good. It is that it shows restraint remains possible inside a system designed to punish it. In AI governance, that is not a final victory. It is not even close. But it is one of the few observable signs that the logic of speed is not yet absolute—and in an industry moving this fast, imperfect progress of that kind is worth defending.